共 17 条
- [4] Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma[J]. Ming Shi Bing Zhang Zi-Rong Tang Zhou-Yun Lei Hui-Fen Wang Yong-Yi Feng Zhen-Ping Fan Dong-Ping Xu Fu-Sheng Wang Division of Biological Engineering,Institute of Infectious Diseases,302 Hospital of PLA,Beijing 100039,China.World Journal of Gastroenterology. 2004(08)
- [6] Antitumor activities of human autologous cytokineinduced killer(CIK)cells against hepatocellular carcinoma cells in vitro and in vivo[J]. Fu-Sheng Wang Ming-Xu Liu Bing Zhang Ming Shi Zhou-Yun Lei Wen-Bing Sun Qing-You Du Ju-Mei Chen,Division of Biological Engineering,Beijing Institute of Infectious Diseases,Beijing 100039,China Wen-Bing Sun,Department of Surgery,Beijing Hospital of Infectious Diseases,Beijing 100039,China.World Journal of Gastroenterology. 2002(03)
- [7] The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study[J] . Jinying Zhang,Lingjun Zhu,Juan Wei,Lingxiang Liu,Yongmei Yin,Yanhong Gu,Yongqian Shu.Journal of Cancer Research and Clinical Oncology . 2012 (6)
- [10] Generation of CD3+CD56+ Cytokine-Induced Killer Cells and Their In Vitro Cytotoxicity against Pediatric Cancer Cells [J]. International Journal of Hematology, 2003, 77 : 175 - 179